Gary S. Stein, PhD, is the Professor and Chairperson of the Department of Biochemistry at the University of Vermont and Director of the Vermont Cancer Center. The central theme of Gary Stein's research has been to discover mechanisms controlling proliferation and differentiation with emphasis on compromised genetic and epigenetic regulatory networks, including noncoding RNA-mediated pathways that are linked with cancer. From the earliest stages of his career, he has pioneered characterization of transcriptional control that governs cell cycle progression and the unique abbreviated cell cycle in pluripotent stem cells. Gary Stein has a major commitment to investigating
Gary S. Stein, PhD, is the Professor and Chairperson of the Department of Biochemistry at the University of Vermont and Director of the Vermont Cancer Center. The central theme of Gary Stein's research has been to discover mechanisms controlling proliferation and differentiation with emphasis on compromised genetic and epigenetic regulatory networks, including noncoding RNA-mediated pathways that are linked with cancer. From the earliest stages of his career, he has pioneered characterization of transcriptional control that governs cell cycle progression and the unique abbreviated cell cycle in pluripotent stem cells. Gary Stein has a major commitment to investigating bone tissue specific gene expression and aberrations that accompany skeletal disease. He has been instrumental in establishing regulatory parameters of breast and prostate cancer metastasis to bone and aberrant gene expression that is linked to Leukemiogenesis. The Stein laboratory is defining functional relationships between the sub-nuclear organization of regulatory proteins and gene expression while pursuing mechanisms that support combinatorial organization and assembly of regulatory machinery in nuclear microenvironments and epigenetic control of cell fate and lineage commitment in biological control and cancer. Gary Stein has mentored more than 175 graduate students, research and clinical fellows and junior faculty. His research program is funded by three program project grants and several RO1 grants as well as a long-term pharmaceutical company grant and foundation funding. He has published more than 850 papers in leading biomedical journals and edited more than 15 books. Gary Stein has organized and chaired numerous international research conferences and serves on advisory panels for United States and foreign government science policy and granting agencies, scientific advisory boards for biotechnology, pharmaceutical and health care organizations and editorial boards of more than 25 journals. He has developed research and science education programs in his institution as well as with universities in Europe, Asia, the Middle East and South America.
Michael Huber studied Chemistry and Biochemistry at the Universities of Erlangen (Germany) and Bern (Switzerland). He obtained his Ph.D. degree in 1997 from the University of Tubingen (Germany). He then joined Gerry Krystal's laboratory at the Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver (Canada) as a postdoctoral fellow to work on SHIP1 function in mast cells. From 1999 to 2007, he was an Assistant Professor in molecular immunology at the University of Freiburg and Max-Planck-Institute for Immunobiology and Epigenetics, Freiburg (Germany), where he later became an Associate Professor (2007 to 2009). Since 2009, he is Full Professor of
Michael Huber studied Chemistry and Biochemistry at the Universities of Erlangen (Germany) and Bern (Switzerland). He obtained his Ph.D. degree in 1997 from the University of Tubingen (Germany). He then joined Gerry Krystal's laboratory at the Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver (Canada) as a postdoctoral fellow to work on SHIP1 function in mast cells. From 1999 to 2007, he was an Assistant Professor in molecular immunology at the University of Freiburg and Max-Planck-Institute for Immunobiology and Epigenetics, Freiburg (Germany), where he later became an Associate Professor (2007 to 2009). Since 2009, he is Full Professor of biochemistry and molecular immunology, Institute of Biochemistry and Molecular Biology, RWTH Aachen University (Germany) and since 2013, he is Director of the Institute of Biochemistry and Molecular Immunology, RWTH Aachen University. His research interests include mast cell biology and signaling, Fc receptor function and signaling, Toll-like receptors and innate immunity with a focus on lipopolysaccharide, CD117/KIT signaling and mastocytosis as well as PI3K/SHIP1 and MAPK signaling.
Dr. Patel (CEO and Medical Director) is an industry veteran with over 25 year's experience in clinical research, principal investigator in over 500 studies, and many publications. He is also the author of several patents in EEC technology and is the past founder of a large CRO (Allied Research International) which in 2006 was named one of Canada's 50 best managed companies. Dr. Patel has sat on several US- FDA and Health Canada-TPD advisory boards and has been invited to present at both the FDA and TPD in his area of expertise. As advisor to major pharmaceutical companies,
Dr. Patel (CEO and Medical Director) is an industry veteran with over 25 year's experience in clinical research, principal investigator in over 500 studies, and many publications. He is also the author of several patents in EEC technology and is the past founder of a large CRO (Allied Research International) which in 2006 was named one of Canada's 50 best managed companies. Dr. Patel has sat on several US- FDA and Health Canada-TPD advisory boards and has been invited to present at both the FDA and TPD in his area of expertise. As advisor to major pharmaceutical companies, Dr Patel has been involved in the development and Canadian launch of several blockbuster allergy and asthma medications in Canada. He also has numerous publications in allergy, respiratory and dermatology. Dr. Patel was recently named Canada's entrepreneur of the year 2008 by Ernst & Young for his accomplishments as an entrepreneur.
Prof. Marcia Regina Brochetto Braga Graduated in Chemistry, BSc by Faculty of Philosophy, Sciences and Letters of Ribeirao Preto, University of Sao Paulo-USP (1976). Professor of Chemistry in high schools (1976-1977). Completed her Master degree in Biological Sciences (Biochemistry) by the University of Sao Paulo (1981), the PhD in Genetics and Molecular Biology by University of Campinas (1989) and Post-doctorate from East CarolinaUniversity School of Medicine (1997). Approved on Public Contest as Free Teaching in Genetics discipline (06/fev/2004) and since then is Adjunct Professor at Universidade Estadual Paulista Julio de Mesquita Filho (UNESP), Rio Claro, SP, Brazil. Have been working
Prof. Marcia Regina Brochetto Braga Graduated in Chemistry, BSc by Faculty of Philosophy, Sciences and Letters of Ribeirao Preto, University of Sao Paulo-USP (1976). Professor of Chemistry in high schools (1976-1977). Completed her Master degree in Biological Sciences (Biochemistry) by the University of Sao Paulo (1981), the PhD in Genetics and Molecular Biology by University of Campinas (1989) and Post-doctorate from East CarolinaUniversity School of Medicine (1997). Approved on Public Contest as Free Teaching in Genetics discipline (06/fev/2004) and since then is Adjunct Professor at Universidade Estadual Paulista Julio de Mesquita Filho (UNESP), Rio Claro, SP, Brazil. Have been working in the fields of Biochemistry, Molecular Biology and Immunology, with emphasis on the cloning and expression of genes from Hymenoptera insect venoms (mainly wasps), biochemical and immunological characterization of recombinant allergens.
Dr. Vural Fidan has recieved his MD and PhD in Hacettepe University. He is deputy director of ENT department. He is an Otorhinolaryngologist at Yunus Emre Goverment Hospital. He worked as a visiting scientist at Yale University ENT and Allegry departments. He has more than 20 SCI indexed articles. Research interests are allergy, otology, rhinology and sleep medicine.
Dr. Vural Fidan has recieved his MD and PhD in Hacettepe University. He is deputy director of ENT department. He is an Otorhinolaryngologist at Yunus Emre Goverment Hospital. He worked as a visiting scientist at Yale University ENT and Allegry departments. He has more than 20 SCI indexed articles. Research interests are allergy, otology, rhinology and sleep medicine.
Born in Teramo (Italy), September 3/9/1959. Degree in Medicine, University of L Aquila. Specialized in Medical Oncology, University of Modena, and in Clinical Immunology and Allergology, Florence Medical School. Research Fellow at the Academic Department of Haematology and Cytogenetics and Institute of Cancer Research, Royal Marsden Hospital, London, 1996 Associate Professor of Internal Medicine, University of L'Aquila, since 2001. Teaching in Internal Medicine, Clinical Immunology and Allergology in various degree courses and specialties of the Faculty of Medicine, University of L Aquila Clinical activity at Teramo Hospital (Internal Medicine) as Director of the Clinical Immunology and Allergology Unit, the Postgraduate Medical School for Specialists
Born in Teramo (Italy), September 3/9/1959. Degree in Medicine, University of L Aquila. Specialized in Medical Oncology, University of Modena, and in Clinical Immunology and Allergology, Florence Medical School. Research Fellow at the Academic Department of Haematology and Cytogenetics and Institute of Cancer Research, Royal Marsden Hospital, London, 1996 Associate Professor of Internal Medicine, University of L'Aquila, since 2001. Teaching in Internal Medicine, Clinical Immunology and Allergology in various degree courses and specialties of the Faculty of Medicine, University of L Aquila Clinical activity at Teramo Hospital (Internal Medicine) as Director of the Clinical Immunology and Allergology Unit, the Postgraduate Medical School for Specialists in Clinical Immunology and Allergology and the Regional Center of Excellence on Osteoporosis, Hospital of Teramo and University of L Aquila, since 2007
Dr. Lue, graduate from Chung Shan Medical University, Taichung, Taiwan (1975-1981). He finished his residency training at the department of pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan and fellowship training at National Taiwan University Hospital, Taipei, Taiwan (1975-1976), becoming attending physician in the department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan. After that, he went to Boston's Children Hospital, Boston, USA for 2 yearsfellowship training (1989-1991). He received many awards and published many papers in famous Journal worldwide. Now, he is a professor, institute of allergy, asthma & immunology, Department of Pediatrics, and president of Chung Shan
Dr. Lue, graduate from Chung Shan Medical University, Taichung, Taiwan (1975-1981). He finished his residency training at the department of pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan and fellowship training at National Taiwan University Hospital, Taipei, Taiwan (1975-1976), becoming attending physician in the department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan. After that, he went to Boston's Children Hospital, Boston, USA for 2 yearsfellowship training (1989-1991). He received many awards and published many papers in famous Journal worldwide. Now, he is a professor, institute of allergy, asthma & immunology, Department of Pediatrics, and president of Chung Shan Medical University, Taichung, Taiwan.
Dr. Makoto Hoshino presently working as a Professor, Department of Respiratory Medicine, Atami Hospital, International University of Health and Welfare, Japan. Makoto Hoshino completed Ph.D from Toho University School of Medicine (Thesis: Breath-by-breath analysis of airway hypersensitivity and ventilatory parameters in bronchial asthma). He is a member in Japanese Society of Allergology, Japanese Respiratory Society, Japanese Society for Respiratory Endoscopy European Respiratory Society, The Japan Lung Cancer Society. He received awards in 1999 from Japan Allergy Foundation Award for Outstanding Research Achievement, Research Training Award for Takeshi-Yanase. In 2001 AstraZeneca Asthma Research Award and 2012 Fukuchi Award, Asian Pacific
Dr. Makoto Hoshino presently working as a Professor, Department of Respiratory Medicine, Atami Hospital, International University of Health and Welfare, Japan. Makoto Hoshino completed Ph.D from Toho University School of Medicine (Thesis: Breath-by-breath analysis of airway hypersensitivity and ventilatory parameters in bronchial asthma). He is a member in Japanese Society of Allergology, Japanese Respiratory Society, Japanese Society for Respiratory Endoscopy European Respiratory Society, The Japan Lung Cancer Society. He received awards in 1999 from Japan Allergy Foundation Award for Outstanding Research Achievement, Research Training Award for Takeshi-Yanase. In 2001 AstraZeneca Asthma Research Award and 2012 Fukuchi Award, Asian Pacific Society of Respirology. He also acted as peer reviewer for few journals and editorial board member in Edorium Journal of Respiratory Medicine, Editorial Board of Global Journal of Respiratory Care, and International Journal of Pulmonology & Clinical Diagnosis.
I received from my Medical Bachelor Degree (in Public Health, 1982), Medical Master Degree (in Occupational and Environmental Health, 1988) and Medical Doctor Degree (in Occupational and Environmental Health, 2001) all from the Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. I have research experiences in Aarhus University (2 years), Denmark, in Hong Kong University of Science and Technology (5 years) and in Nanyang Technological University, Singapore (one year). I have been engaged in the scientific research work on Environmental Health for 33 years since I graduated as Medical Bachelor from university. I had worked in Wuhan
I received from my Medical Bachelor Degree (in Public Health, 1982), Medical Master Degree (in Occupational and Environmental Health, 1988) and Medical Doctor Degree (in Occupational and Environmental Health, 2001) all from the Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. I have research experiences in Aarhus University (2 years), Denmark, in Hong Kong University of Science and Technology (5 years) and in Nanyang Technological University, Singapore (one year). I have been engaged in the scientific research work on Environmental Health for 33 years since I graduated as Medical Bachelor from university. I had worked in Wuhan Center for Disease Control (CDC) for the previous 18 years, and then I have been working in the School of Life Sciences, Central China Normal University for the recent 15 years; there I built up the Laboratory of Environmental Biomedicine. Now I am the head and PI of this Lab.
Dr. Keiji Sugiura is a director of department of Environmental Dermatology and Allergology, Daiichi Clinic in Japan. He graduated from postgraduate school of Fujita Health University and obtained Ph.D. degree in 2001. After then, he studied about cutaneous allergy and skin surgery at Nagoya University School of Medicine, and he researched about histopathology and Langerhans cells of dermatoses at Institute for Comprehensive Medical Science, Pathological Cytology, Fujita Health University. His main research area is Langerhans cell in cutaneous disease. Specialty is skin surgery and cutaneous allergy. Dr.Keiji Sugiura belonged to Daiichi Clinic from 2005, and he has been a director
Dr. Keiji Sugiura is a director of department of Environmental Dermatology and Allergology, Daiichi Clinic in Japan. He graduated from postgraduate school of Fujita Health University and obtained Ph.D. degree in 2001. After then, he studied about cutaneous allergy and skin surgery at Nagoya University School of Medicine, and he researched about histopathology and Langerhans cells of dermatoses at Institute for Comprehensive Medical Science, Pathological Cytology, Fujita Health University. His main research area is Langerhans cell in cutaneous disease. Specialty is skin surgery and cutaneous allergy. Dr.Keiji Sugiura belonged to Daiichi Clinic from 2005, and he has been a director of Daiichi Clinic since 2007. He was an invited speaker, as a faculty, about dendritic cells in European Society of Cardiology 2007 (in Austria). Now he is an editor and reviewer of some international medical journal. His currently interesting is allergy peculiar to Japanese foods (ex. soy sauce, raw fish) and occupational allergy.
Dr. Francisco Vazquez-Nava received Doctorate in 2009 from University of Granada, Spain. He worked as Specialist in Immunology and Allergy at National Council of Clinical Inmunology and Allergy and Specialist in Family Medicine at Faculty of Medicine of Tampico Autonomous University of Tamaulipas. Currently he working as a Professor, full time researcher, allergy and immunology. Department of Research of the Faculty of Medicine of Tampico Autonomous University of Tamaulipas. He has published more than 50 research articles and written two books.
Dr. Francisco Vazquez-Nava received Doctorate in 2009 from University of Granada, Spain. He worked as Specialist in Immunology and Allergy at National Council of Clinical Inmunology and Allergy and Specialist in Family Medicine at Faculty of Medicine of Tampico Autonomous University of Tamaulipas. Currently he working as a Professor, full time researcher, allergy and immunology. Department of Research of the Faculty of Medicine of Tampico Autonomous University of Tamaulipas. He has published more than 50 research articles and written two books.
Dr. Sicen Wang graduated with a BSc(1997) in Pharmacy from Xi'an Medical University and a MSc(2002) and PhD(2006) in Pharmaceutical Analysis from Xi'an Jiaotong University, China. He is currently a professor and vice dean at School of Pharmacy, Xi'an Jiaotong University. Dr. Wang is also the group leader of Screening active compounds from TCM. His research interest revolves around screening the active components from natural medicines and developing new drugs, and pharmaceutical Quality Control using various analytical techniques. The main objective of this work is to discover active compounds from Chinese folk herb medicine. Dr Wang has published over 40
Dr. Sicen Wang graduated with a BSc(1997) in Pharmacy from Xi'an Medical University and a MSc(2002) and PhD(2006) in Pharmaceutical Analysis from Xi'an Jiaotong University, China. He is currently a professor and vice dean at School of Pharmacy, Xi'an Jiaotong University. Dr. Wang is also the group leader of Screening active compounds from TCM. His research interest revolves around screening the active components from natural medicines and developing new drugs, and pharmaceutical Quality Control using various analytical techniques. The main objective of this work is to discover active compounds from Chinese folk herb medicine. Dr Wang has published over 40 research papers(SCOPUS h-index 11, >270 citstions). He is a review editor and expert reviewer for several international Journals. Dr Wang has supervised 11 post graduated students.
Dr. De-sheng Wang graduated from Fujian Medical University, Fuzhou, China and received His MD from the Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine , Geneva University, Switzerland. His clinical and research focuses on the diseases of rhinologic field such as rhinosinusitis, nasal polyps, and tumors in sinonasal cavity, nasopharynx and larynx . Now, he is a professor in Department of Otorhinolaryngology, Affiliated Union Hospital, Fujian Medical University, P.R China
Dr. De-sheng Wang graduated from Fujian Medical University, Fuzhou, China and received His MD from the Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine , Geneva University, Switzerland. His clinical and research focuses on the diseases of rhinologic field such as rhinosinusitis, nasal polyps, and tumors in sinonasal cavity, nasopharynx and larynx . Now, he is a professor in Department of Otorhinolaryngology, Affiliated Union Hospital, Fujian Medical University, P.R China
Professor Guangqiao Zeng, MD, graduated from Department of Clinical Medicine, Sun Yat-sen's University of Medical Sciences in 1989. He was a specialist in urology and presently he is a consultant physician and a medical researcher at the State Key Laboratory of Respiratory Disease (SKLRD), First Affiliated Hospital of Guangzhou Medical University. He has been in charge of scientific publication at SKLRD ever since. Professor Zeng is active as a scientific medical writer and medical journal editor, and plays an important role on the Editorial Board of several Chinese medical journals. In 2009, Professor Zeng launched a new journal, the Journal
Professor Guangqiao Zeng, MD, graduated from Department of Clinical Medicine, Sun Yat-sen's University of Medical Sciences in 1989. He was a specialist in urology and presently he is a consultant physician and a medical researcher at the State Key Laboratory of Respiratory Disease (SKLRD), First Affiliated Hospital of Guangzhou Medical University. He has been in charge of scientific publication at SKLRD ever since. Professor Zeng is active as a scientific medical writer and medical journal editor, and plays an important role on the Editorial Board of several Chinese medical journals. In 2009, Professor Zeng launched a new journal, the Journal of Thoracic Disease (JTD), which has now been indexed in National Library of Medicine (NLM) and Thomson Reuters' master journal list. He works hard and has also helped a great number of clinicians in successful publishing of biomedical articles, including those in Lancet, Chest, Thorax, British Medical Journal, American Journal of Respiratory and Critical Care Medicine.
Ruey-Hong Wong completed his Ph.D. in Occupational Medicine and Industrial Hygiene at National Taiwan University in 2001. Now, he is a professor of the Department of Public Health at Chung Shan Medical University (Taiwan). His research focuses on the environmental and molecular epidemiology. His past relevant research experience was to establish an occupational cohort of workers exposed to vinyl chloride monomer in Taiwan, and investigating the risk factors and mechanisms of vinyl chloride monomer related liver diseases, particularly for liver cancer in this cohort. Current research interests include the risk factors and molecular mechanisms of airway disease and immune related
Ruey-Hong Wong completed his Ph.D. in Occupational Medicine and Industrial Hygiene at National Taiwan University in 2001. Now, he is a professor of the Department of Public Health at Chung Shan Medical University (Taiwan). His research focuses on the environmental and molecular epidemiology. His past relevant research experience was to establish an occupational cohort of workers exposed to vinyl chloride monomer in Taiwan, and investigating the risk factors and mechanisms of vinyl chloride monomer related liver diseases, particularly for liver cancer in this cohort. Current research interests include the risk factors and molecular mechanisms of airway disease and immune related diseases (particularly ankylosing spondylitis and childhood asthma). His results will provide insights into the possible mechanism of disease development. Research findings have also attracted considerable international attention and evoked public interest.
Xin Yao obtained his MBBS and Ph.D. degrees from Nanjing Medical University, Nanjing, Jiangsu, China. Yao serves as a Professor of respiratory medicine in Nanjing Medical University. He is also a consultant of respiratory medicine in First Affiliated Hospital of Nanjing Medical University. Since 1998, he joined Professor Yin Kai Sheng's group, mainly on asthma research. Yao;s research is focused on the mechanism of airway disease and the biomarkers of asthma and COPD. His research is currently funded by grants from NSFC, JSNSF, and collaborating with Professor Peter Barnes and Ian Adcock from Imperial College, London, UK.
Xin Yao obtained his MBBS and Ph.D. degrees from Nanjing Medical University, Nanjing, Jiangsu, China. Yao serves as a Professor of respiratory medicine in Nanjing Medical University. He is also a consultant of respiratory medicine in First Affiliated Hospital of Nanjing Medical University. Since 1998, he joined Professor Yin Kai Sheng's group, mainly on asthma research. Yao;s research is focused on the mechanism of airway disease and the biomarkers of asthma and COPD. His research is currently funded by grants from NSFC, JSNSF, and collaborating with Professor Peter Barnes and Ian Adcock from Imperial College, London, UK.
He completed his undergraduate studies in the University of Hong Kong and was then awarded a Commonwealth scholarship to pursue his PhD studies in the Memorial University of Newfoundland in Canada. He received postdoctoral training at the University of California in San Francisco,USA and conducted sabbatical research at Imperial College London UK. His research interests include hormones, lectins, antifungal proteins, ribosome inactivating proteins, enzymes, polysaccharides and protease inhibitors derived from plants, medicinal plants, fungi and animals. He has authored over 600 papers registered in PbMed and over 80 invited book chapters. He has served as reviewer for many journals.
He completed his undergraduate studies in the University of Hong Kong and was then awarded a Commonwealth scholarship to pursue his PhD studies in the Memorial University of Newfoundland in Canada. He received postdoctoral training at the University of California in San Francisco,USA and conducted sabbatical research at Imperial College London UK. His research interests include hormones, lectins, antifungal proteins, ribosome inactivating proteins, enzymes, polysaccharides and protease inhibitors derived from plants, medicinal plants, fungi and animals. He has authored over 600 papers registered in PbMed and over 80 invited book chapters. He has served as reviewer for many journals.
Zhenwen Zhou obtained his PhD degree from the Sun Yet-Sen University in 2007. He joined clinical microbiology laboratory in Guangzhou children and medical center in 2007. He worked as a visiting scientist in pediatric allergy and immunology at Mount Sinia medicine school during September, 2013 to October, 2014. His research focuses on the clinical microbiology and pediatric allergy. Recently he developed a new vaccine using probiotic Bacillus subtilis as vehicle, peanut major allergens (Ara h1, Ara h2, Ara h3) fusion with CTB as candidates for preventing peanut allergic anaphylaxis. Dr Zhou has published over 15 peer-reviewed manuscripts in international journals.
Zhenwen Zhou obtained his PhD degree from the Sun Yet-Sen University in 2007. He joined clinical microbiology laboratory in Guangzhou children and medical center in 2007. He worked as a visiting scientist in pediatric allergy and immunology at Mount Sinia medicine school during September, 2013 to October, 2014. His research focuses on the clinical microbiology and pediatric allergy. Recently he developed a new vaccine using probiotic Bacillus subtilis as vehicle, peanut major allergens (Ara h1, Ara h2, Ara h3) fusion with CTB as candidates for preventing peanut allergic anaphylaxis. Dr Zhou has published over 15 peer-reviewed manuscripts in international journals.
Dr. Sang Hag Lee graduate from Korea University, College of Medicine, Seoul, Korea and received His PhD from the Department of Otorhinolaryngology-Head and Neck Surgery, Korea University, College of Medicine, Seoul, Korea. He finished residency training at the Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Korea. His clinical and research focuses the diseases of rhinologic field such as rhinosinusitis, nasal polyps, corrective rhinoplasty, and benign and malignant tumor in sinonasal cavity. He received many awards and published many papers in famous journal worldwide. Now, he is a professor in Department of Otorhinolaryngology-Head and Neck Surgery,
Dr. Sang Hag Lee graduate from Korea University, College of Medicine, Seoul, Korea and received His PhD from the Department of Otorhinolaryngology-Head and Neck Surgery, Korea University, College of Medicine, Seoul, Korea. He finished residency training at the Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Korea. His clinical and research focuses the diseases of rhinologic field such as rhinosinusitis, nasal polyps, corrective rhinoplasty, and benign and malignant tumor in sinonasal cavity. He received many awards and published many papers in famous journal worldwide. Now, he is a professor in Department of Otorhinolaryngology-Head and Neck Surgery, Korea University, College of Medicine, Seoul, Korea.
Mohmmad Hossein Boskabady is a Professor Finishing MD in Mashhad University of Medical in 1981 and PhD in London University, Charring Cross and Westminister Medical School in 1991. He published more than 160 papers in English language and more than 10 in Farsi Presenting more than 240 abstract in National and International Congresses,Receiving several national research awards. His research interests includes Asthma, COPD, Airway Pharmacology, Chemical Earfare and Respiratory Diseases, Chemical Earfare and Respiratory Diseases, Occupational Respiratory Diseases, Pulmonary Function Tests, Medicinal Plants and Lung Diseases.
Mohmmad Hossein Boskabady is a Professor Finishing MD in Mashhad University of Medical in 1981 and PhD in London University, Charring Cross and Westminister Medical School in 1991. He published more than 160 papers in English language and more than 10 in Farsi Presenting more than 240 abstract in National and International Congresses,Receiving several national research awards. His research interests includes Asthma, COPD, Airway Pharmacology, Chemical Earfare and Respiratory Diseases, Chemical Earfare and Respiratory Diseases, Occupational Respiratory Diseases, Pulmonary Function Tests, Medicinal Plants and Lung Diseases.
Dr. Antonio Celso Dias Pais Pereira completed his Ph.D from Dynamic of allergic reaction and specific immunotherapy in 2009. Presently he is head Chief Prof of Clinic Immunology, Medicine Faculty. Coimbra University. Portugal. He received 34 Scientific Awards on the field of Allergology and Clinical Immunology and Participated in 42 Scientific Committee and/or Organising Committee Meetings/Congress (national and international). He has edited 4 scientific books (1 international), and has more than 300 scientific publications including book chapters, and scientific papers. He author and/or co-Author of over 400 abstracts related to the research projects developed and presented at scientific events. He
Dr. Antonio Celso Dias Pais Pereira completed his Ph.D from Dynamic of allergic reaction and specific immunotherapy in 2009. Presently he is head Chief Prof of Clinic Immunology, Medicine Faculty. Coimbra University. Portugal. He received 34 Scientific Awards on the field of Allergology and Clinical Immunology and Participated in 42 Scientific Committee and/or Organising Committee Meetings/Congress (national and international). He has edited 4 scientific books (1 international), and has more than 300 scientific publications including book chapters, and scientific papers. He author and/or co-Author of over 400 abstracts related to the research projects developed and presented at scientific events. He is member of 8 Scientific Societies and an associate editor of 4 scientific Journals related to Allergy and Clinical Immunology. Research interests includes Mechanisms of IgE-mediated allergic inflammation in respiratory allergies, including the effects of local response in the early induction of systemic effects, particularly those involved in immune system organs and central immuno-inflammatory responses. Mechanisms of specific immunotherapy with allergens, particularly those related to gene expression response.
Professor Abdulghani Mohamad Alsamarai completed his undergraduate studies at College of Medicine, Basrah University in 1977 and received his MGUM degree in Genitourinary Medicine [1988] and Ph D in Clinical Virology [1986] from Sheffield University, UK. He completed 31 years working as consultant in Allergy, Dermatology, Infectious Diseases and Medical Education in Basrah and Tikrit Universities.He appointed as Dean of Tikrit University College of Medicine from 2000 to 2003, Chairman of Tikrit University Promotion Committee and a Dean of College of Applied Medical Sciences, Lahaye International University. Since 1977 his research focused on several issues including fungal, viral, bacterial, allergic
Professor Abdulghani Mohamad Alsamarai completed his undergraduate studies at College of Medicine, Basrah University in 1977 and received his MGUM degree in Genitourinary Medicine [1988] and Ph D in Clinical Virology [1986] from Sheffield University, UK. He completed 31 years working as consultant in Allergy, Dermatology, Infectious Diseases and Medical Education in Basrah and Tikrit Universities.He appointed as Dean of Tikrit University College of Medicine from 2000 to 2003, Chairman of Tikrit University Promotion Committee and a Dean of College of Applied Medical Sciences, Lahaye International University. Since 1977 his research focused on several issues including fungal, viral, bacterial, allergic and dermatologic diseases. Recently, he focuses on the role of oxidants / antioxidants, non invasive biomarkers of allergic diseases. Professor Alsamarai has received a good contribution from National and International agencies to support his research on drug formulation, searching for new drugs, bioavailability of drugs, Plant products research, National Programme for Prevention and Control of Disease, and Community Health Promotion Research.
Dr. Qalaji earned his Ph.D. degree in Pharmaceutics from the University of Manitoba. He received several international, national, provincial, and institutional awards and recognitions. He was awarded Strategic Training in Allergy Research (ST*AR) Award from the American Academy of Allergy, Asthma & Immunology's (AAAAI), The Canadian Foundation for Pharmacy (CFP) National Award, Manitoba Health Research Council (MHRC) Award, Honourable Mention by Manitoba Health Research Council (MHRC), Manitoba Institute of Child Health (MICH) Award, Manitoba Pharmaceutical Association (MPhA) Award, University of Manitoba Fellowship, and Ebla Private University recognition. He worked as a formulation scientist for ENWAVE Corp. at the University of
Dr. Qalaji earned his Ph.D. degree in Pharmaceutics from the University of Manitoba. He received several international, national, provincial, and institutional awards and recognitions. He was awarded Strategic Training in Allergy Research (ST*AR) Award from the American Academy of Allergy, Asthma & Immunology's (AAAAI), The Canadian Foundation for Pharmacy (CFP) National Award, Manitoba Health Research Council (MHRC) Award, Honourable Mention by Manitoba Health Research Council (MHRC), Manitoba Institute of Child Health (MICH) Award, Manitoba Pharmaceutical Association (MPhA) Award, University of Manitoba Fellowship, and Ebla Private University recognition. He worked as a formulation scientist for ENWAVE Corp. at the University of British Columbia in Vancouver, British Columbia, Canada. Dr. Qalaji's research was focused on the formulation and drug delivery of different dosage forms (e.g. solids, semisolids, injectables, ophthalmics, sustained release delivery systems, nanoparticles, vaccines).Dr. Qalaji has several publications and patents applications (US and international) for his research. His current research interest is focused on the formulation and delivery of poorly absorbed drugs using nanotechnology through non-invasive and user-friendly routes of administration. Dr. Qalaji received several research grants and trained and mentored several students in his laboratory from the College of Pharmacy and the College of Dental Medicine at Nova Southeastern University.
Dr. Imran Iftikhar is an Associate Professor in the Division of Pulmonary, Critical care and Sleep Medicine. After 3 years of training in Internal Medicine at Fairview Hospital/Cleveland Clinic, Cleveland, Ohio, he completed 2 years of training in Pulmonary Medicine at the University of South Carolina, School of Medicine in 2010. He then, completed a year of training in Sleep Medicine at the Ohio State University, Columbus, Ohio. After his fellowship in Sleep Medicine, he joined the faculty of University of South Carolina, School of Medicine in July 2011. Dr. Iftikhar has published in several peer-reviewed journals and serves on
Dr. Imran Iftikhar is an Associate Professor in the Division of Pulmonary, Critical care and Sleep Medicine. After 3 years of training in Internal Medicine at Fairview Hospital/Cleveland Clinic, Cleveland, Ohio, he completed 2 years of training in Pulmonary Medicine at the University of South Carolina, School of Medicine in 2010. He then, completed a year of training in Sleep Medicine at the Ohio State University, Columbus, Ohio. After his fellowship in Sleep Medicine, he joined the faculty of University of South Carolina, School of Medicine in July 2011. Dr. Iftikhar has published in several peer-reviewed journals and serves on the editorial board for several journals and as ad-hoc reviewer for several others.
Ersagun Karaguzel graduated from Hacettepe University, Faculty of Medicine, Turkey in 2001 and trained in Urology at the Ministry of Health Ankara Education and Training Hospital II. Urology Clinic in Turkey. Since 2010 Dr. Karaguzel is working in the department of Urology at the Karadeniz Technical University, Faculty of Medicine as a Associate Professor. He is a member of the European Association of Urology (EAU). His clinical and research interest is Pediatric Urology. He publihed in several peer-reviewed journals.
Ersagun Karaguzel graduated from Hacettepe University, Faculty of Medicine, Turkey in 2001 and trained in Urology at the Ministry of Health Ankara Education and Training Hospital II. Urology Clinic in Turkey. Since 2010 Dr. Karaguzel is working in the department of Urology at the Karadeniz Technical University, Faculty of Medicine as a Associate Professor. He is a member of the European Association of Urology (EAU). His clinical and research interest is Pediatric Urology. He publihed in several peer-reviewed journals.
Dr. Sanchez has completed his PhD at the age of 23 years from Cadiz University and postdoctoral studies from Cadiz University Hospital and School of Medicine. During 8 years (2000-2008) he was Chief of Pediatric Department of the District Hospital in Cadiz and from 2008 until nowadays he is the Director of the Section of Pediatric Allergy Pneumology of the University Hospital Puerto Real in Cadiz (Spain), he works also as Professor of Pediatrics at the University of Cadiz. He is also President of the Association of Children's Allergy southern Spain and belongs to the Food Allergy Committee of
Dr. Sanchez has completed his PhD at the age of 23 years from Cadiz University and postdoctoral studies from Cadiz University Hospital and School of Medicine. During 8 years (2000-2008) he was Chief of Pediatric Department of the District Hospital in Cadiz and from 2008 until nowadays he is the Director of the Section of Pediatric Allergy Pneumology of the University Hospital Puerto Real in Cadiz (Spain), he works also as Professor of Pediatrics at the University of Cadiz. He is also President of the Association of Children's Allergy southern Spain and belongs to the Food Allergy Committee of the Spanish Society of Pediatric Allergy. The main topics of research and work in his hospital are those related to food allergy, developing for more than four years ago, desensitization techniques in milk and egg allergy, with more than 40 children who tolerate both foods. In the coming months will begin work desensitization to fish (hake) in collaboration with several Spanish hospitals.
Henry Mok obtained his PhD degree from the University of Cambridge in 1996 worked on NMR structure of E2 DNA binding domain of HPV-16. He joined Julie Forman-Kay's laboratory in Hospital for Sick Children, Toronto, as a postdoctoral fellow from 1996 to 1999 worked on protein folding of the drk SH3 domain. In 2000, he joined the Department of Biological Sciences at the National University of Singapore to start his laboratory investigating structure/function relationship of proteins related to human diseases. Currently, his laboratory is investigating the structure of proteins from the type III and VI secretion systems
Henry Mok obtained his PhD degree from the University of Cambridge in 1996 worked on NMR structure of E2 DNA binding domain of HPV-16. He joined Julie Forman-Kay's laboratory in Hospital for Sick Children, Toronto, as a postdoctoral fellow from 1996 to 1999 worked on protein folding of the drk SH3 domain. In 2000, he joined the Department of Biological Sciences at the National University of Singapore to start his laboratory investigating structure/function relationship of proteins related to human diseases. Currently, his laboratory is investigating the structure of proteins from the type III and VI secretion systems of pathogenic bacteria, as well as proteins involved in dust mite allergy and atopic dermatitis. Research interests includes structure/function relationship of proteins involved in human diseases by NMR and X-ray crystallography.
Dr Shirasaki graduate from Sapporo Medical University, Japan. He obtained his Ph.D.degree in 1990 from Sapporo Medical University. From 1991-1993, he then joined Professor Peter J Barnes's laboratory in National Heart and Lung Institute (London) as postdoctoral fellow to work on PAF receptor in human lung. After that, he returned to Sapporo Medical University as ENT doctor. He has been the international member of AAAAI since 2002. He received the prize of Japan Rhinologic Society in 2005 and the outstanding abstract awards of 2012 WAO International Scientific Conference. Research Interests include the roles of chemical mediators in allergic airway diseases.
Dr Shirasaki graduate from Sapporo Medical University, Japan. He obtained his Ph.D.degree in 1990 from Sapporo Medical University. From 1991-1993, he then joined Professor Peter J Barnes's laboratory in National Heart and Lung Institute (London) as postdoctoral fellow to work on PAF receptor in human lung. After that, he returned to Sapporo Medical University as ENT doctor. He has been the international member of AAAAI since 2002. He received the prize of Japan Rhinologic Society in 2005 and the outstanding abstract awards of 2012 WAO International Scientific Conference. Research Interests include the roles of chemical mediators in allergic airway diseases.
Dr. S. Tolga Yavuz is an Associate Professor in the Department of Pediatric Allergy and Clinical Immunology. After 4 years of residency in Pediatrics at Gulhane Military School of Medicine, Ankara, Turkey, he completed 3 years of fellowship in Pediatric Allergy and Immunology at the University of Hacettepe Ankara, School of Medicine in 2011. After his fellowship, he joined the Pediatrics Department of GATA School of Medicine in January 2012. He received many awards and published many papers in famous journal worldwide. His primary areas of interest are insect venom allergy, food allergy and childhood asthma.
Dr. S. Tolga Yavuz is an Associate Professor in the Department of Pediatric Allergy and Clinical Immunology. After 4 years of residency in Pediatrics at Gulhane Military School of Medicine, Ankara, Turkey, he completed 3 years of fellowship in Pediatric Allergy and Immunology at the University of Hacettepe Ankara, School of Medicine in 2011. After his fellowship, he joined the Pediatrics Department of GATA School of Medicine in January 2012. He received many awards and published many papers in famous journal worldwide. His primary areas of interest are insect venom allergy, food allergy and childhood asthma.
Dr. Freya Helena Campos was for 1 year an Associate Professor in the Division of Allergy and Clinical Immunology in National Medical Center XXI Century of the Mexican Social Security Institute. She is currently head of allergy department in the South Central High Specialty Hospital PEMEX, Picacho. After 2 years of training in Internal Medicine he completed 2 years of training in Allergy and Clinical Immunology at the National Medical Center XXI Century of the Mexican Social Security Institute. She is a junior member in World Allergy Organization (WAO) American College of Allergy, Asthma & Immunology (ACAAI), European Academy
Dr. Freya Helena Campos was for 1 year an Associate Professor in the Division of Allergy and Clinical Immunology in National Medical Center XXI Century of the Mexican Social Security Institute. She is currently head of allergy department in the South Central High Specialty Hospital PEMEX, Picacho. After 2 years of training in Internal Medicine he completed 2 years of training in Allergy and Clinical Immunology at the National Medical Center XXI Century of the Mexican Social Security Institute. She is a junior member in World Allergy Organization (WAO) American College of Allergy, Asthma & Immunology (ACAAI), European Academy of Allergy and. Clinical Immunology (EAACI) and Member College of Clinical Immunology and Allergy Mexico, Has received awards in 2011 as Outstanding Junior Award Abstract in the XXII World Allergy Congress, A First Place Competition Jaque Matte. XIX National Congress of Asthma, Allergy and Immunology Pediatric. July 2012. She was the First Mexican Representative in the Fit Bowl 2012 Annual Scientific Meeting by The American College of Allergy, Asthma & Immunology. And has published in the last years in the field of latex allergy, drug allergy, DRESS syndrome and primary immunodeficiencies. She has participated as a reviewer for the WAO and the International Journal of Plant Biology and Research. And as Professor in other symposia in her country.
Joseph F. Merola, MD, MMSc, is an Instructor at Harvard Medical School (HMS), and Director of Clinical Trials at Brigham and Women's Hospital (BWH), Dept of Dermatology. He is the Co-Director of the Center for Skin and Related Musculoskeletal Diseases. Dr. Merola is one of a handful of physicians in the US trained in Dermatology, Rheumatology and Internal Medicine. His clinical work and interests are at the interface of Rheumatology and Dermatology. His current research is focused on outcome measures in psoriasis and clinical research in the area of systemic/cutaneous lupus and psoriasis/psoriatic arthritis. Education: NYU School of Medicine, MD
Joseph F. Merola, MD, MMSc, is an Instructor at Harvard Medical School (HMS), and Director of Clinical Trials at Brigham and Women's Hospital (BWH), Dept of Dermatology. He is the Co-Director of the Center for Skin and Related Musculoskeletal Diseases. Dr. Merola is one of a handful of physicians in the US trained in Dermatology, Rheumatology and Internal Medicine. His clinical work and interests are at the interface of Rheumatology and Dermatology. His current research is focused on outcome measures in psoriasis and clinical research in the area of systemic/cutaneous lupus and psoriasis/psoriatic arthritis. Education: NYU School of Medicine, MD (AOA), Internal Medicine Internship at the University of Pennsylvania, Dermatology Resident and Chief Resident at the NYU Department of Dermatology, completed Internal Medicine training and Rheumatology fellowship at The Brigham and Women's Hospital (BWH). He received his MMSc in clinical translational research from Harvard Medical School. His disease areas of expertise and interests include psoriasis/psoriatic arthritis, systemic and skin lupus as well as dermatomyositis, vasculitis, scleroderma and other autoimmune and connective tissue disorders. He serves on the board of the International Dermatology Outcomes Measures group and the medical board of the National Psoriasis Foundation. He is a consultant, investigator and serves on the scientific advisory-boards of several biotech corporations
Dr. Haibin wang received his Ph.D. from Peking University Health Science Center, China in 1999, and completed his postdoctoral fellowship training in 2002 at Division of Allergy, Inflammation and Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School. He has been remaining on the faculty of the same Division at Harvard for 12 years. His research focuses on the immunoregulatory roles of eosinophils, including roles for eosinophils as antigenÂpresenting cells in regulating regional and systemic T cell responses in allergic diseases including asthma, and roles of eosinophil-secreted cytokines in directing T cell differentiation and in B cell priming and activation.
Dr. Haibin wang received his Ph.D. from Peking University Health Science Center, China in 1999, and completed his postdoctoral fellowship training in 2002 at Division of Allergy, Inflammation and Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School. He has been remaining on the faculty of the same Division at Harvard for 12 years. His research focuses on the immunoregulatory roles of eosinophils, including roles for eosinophils as antigenÂpresenting cells in regulating regional and systemic T cell responses in allergic diseases including asthma, and roles of eosinophil-secreted cytokines in directing T cell differentiation and in B cell priming and activation. He has authored/co-authored over 20 peer-reviewed publications in international journals, books and conference proceedings.
Dr. Chiu received her Ph.D. from Rutgers University and was a postdoctoral fellow in immunology at Princeton University. Currently she is a Research Assistant Professor in the lab of Dr. Christopher Ritchlin where her research is centrally focused on DC-STAMP, a transmembrane protein essential for cell-cell fusion during osteoclastogenesis. Her reserach projects include investigating the role of DC-STAMP in signaling and bone healing and the regulation of cell-to-cell fusion during osteoclast differentiation.
Dr. Chiu received her Ph.D. from Rutgers University and was a postdoctoral fellow in immunology at Princeton University. Currently she is a Research Assistant Professor in the lab of Dr. Christopher Ritchlin where her research is centrally focused on DC-STAMP, a transmembrane protein essential for cell-cell fusion during osteoclastogenesis. Her reserach projects include investigating the role of DC-STAMP in signaling and bone healing and the regulation of cell-to-cell fusion during osteoclast differentiation.
Dr Chan, of the division of Allergy, Asthma & Immunology at Children's Mercy Hospital, earned her PhD in viral immunology at McMaster University in Canada, and conducted postdoctoral training at the Hospital for Sick Children in Toronto. Her early work was on hemorrhagic fever viruses and Epstein Barr virus. She has held faculty positions at the National Jewish Research Center, Denver and the Department of Microbiology, University of Kansas, studying human B cell immunology, B cell activation and regulation of the immunoglobulin IgE and its relationship to allergy. She worked in the Biotechnology industry, serving as Director of Research/Development for
Dr Chan, of the division of Allergy, Asthma & Immunology at Children's Mercy Hospital, earned her PhD in viral immunology at McMaster University in Canada, and conducted postdoctoral training at the Hospital for Sick Children in Toronto. Her early work was on hemorrhagic fever viruses and Epstein Barr virus. She has held faculty positions at the National Jewish Research Center, Denver and the Department of Microbiology, University of Kansas, studying human B cell immunology, B cell activation and regulation of the immunoglobulin IgE and its relationship to allergy. She worked in the Biotechnology industry, serving as Director of Research/Development for two different companies where she established departments to develop diagnostic immunoassays and cell based assays. She co-authored 5 patents for therapeutic approaches to autoimmune diseases. At this time, her lab studies B cell regulation, single nucleotide polymorphisms and environmental influences as they relate to pathology and drug responsiveness in asthma
Efren Rael is an Assistant Professor of Allergy/Immunology at Penn State, Hershey Medical Center. He completed his Medical Doctorate from Boston University School of Medicine. He received Allergy/Immunology Fellowship Certificate from University of South Florida, Department of Allergy/Immunology. He published more than 40 peer review publications in different scientific journals. He acted as sub-investigator for many clinical research studies. He received certificates from American Board of Internal Medicine and American Board of Allergy and Immunology and he is the member in many international Organizations including World Allergy Organization (WAO), along with these he has committee membership in AAAAI Genetics,
Efren Rael is an Assistant Professor of Allergy/Immunology at Penn State, Hershey Medical Center. He completed his Medical Doctorate from Boston University School of Medicine. He received Allergy/Immunology Fellowship Certificate from University of South Florida, Department of Allergy/Immunology. He published more than 40 peer review publications in different scientific journals. He acted as sub-investigator for many clinical research studies. He received certificates from American Board of Internal Medicine and American Board of Allergy and Immunology and he is the member in many international Organizations including World Allergy Organization (WAO), along with these he has committee membership in AAAAI Genetics, Molecular Biology & Epidemiology Member, AAAAI Committee on the Underserved Member, AAAAI Asthma Diagnosis, Assessment and Treatment Committee Member.
Dr. Alexei Gonzalez-Estrada received his MD at the Anahuac University School of Medicine in Mexico. He completed an Internal Medicine residency at the Cleveland Clinic Foundation and is a current Allergy and Clinical Immunology Fellow at the same Institution. He has authored/co-authored over 20 peer-reviewed publications in international journals and conferences. He received the prestigious Clemens Von Pirquet Award for best research by a fellow from the American College of Allergy, Asthma and Immunology. His research interests include anaphylaxis, drug allergy, and social media tools in patient education. My research interests include anaphylaxis, perioperative anaphylaxis, drug allergy/reactions, chronic idiopathic
Dr. Alexei Gonzalez-Estrada received his MD at the Anahuac University School of Medicine in Mexico. He completed an Internal Medicine residency at the Cleveland Clinic Foundation and is a current Allergy and Clinical Immunology Fellow at the same Institution. He has authored/co-authored over 20 peer-reviewed publications in international journals and conferences. He received the prestigious Clemens Von Pirquet Award for best research by a fellow from the American College of Allergy, Asthma and Immunology. His research interests include anaphylaxis, drug allergy, and social media tools in patient education. My research interests include anaphylaxis, perioperative anaphylaxis, drug allergy/reactions, chronic idiopathic urticaria, and social media tools in patients education.
I received my PhD in Biophysics from the University of Illinois at Urbana-Champaign in 1990, and did one year of post-doctoral fellowship at the same university. I started my career in Immunology at National Institutes of Health in 1991, studying the mechanism of leukocyte trafficking in immune system. My research has been focused on the characterization of chemoattractants and their receptors, including chemokines, chemokine receptors and a group of pattern recognition classic chemoattractant receptors, such as N-formyl peptide receptors. My research work in this field started with molecular cloning and characterization of chemoattractant receptors both in human
I received my PhD in Biophysics from the University of Illinois at Urbana-Champaign in 1990, and did one year of post-doctoral fellowship at the same university. I started my career in Immunology at National Institutes of Health in 1991, studying the mechanism of leukocyte trafficking in immune system. My research has been focused on the characterization of chemoattractants and their receptors, including chemokines, chemokine receptors and a group of pattern recognition classic chemoattractant receptors, such as N-formyl peptide receptors. My research work in this field started with molecular cloning and characterization of chemoattractant receptors both in human and mice, and then created chemokine and chemoattractant receptor knockout mice and analyzed biological roles of these molecules in animal disease models. More recently, my research interest is in chemokine receptor related human genetic diseases.
Xuehua XU obtained bachelor and master degrees from Harbin Normal University, China in 1996. As a visiting student, I went to Japan (Tsukuba University Department of Biology) in 1997 and got into PhD program in Biotechnology in the following year. In June 2002, I joined Chemotaxis Signaling Section, Laboratory of Immunogenetics in National Institutes of Allergy and Infectious Diseases (NIAID/NIH) as a visiting fellow. My research focused on developing and applying state of art imaging technology to monitor signaling network of G protein coupled receptor mediated chemotaxis in model organism Dictyostelium. Four years later, I was recruited as an assistant
Xuehua XU obtained bachelor and master degrees from Harbin Normal University, China in 1996. As a visiting student, I went to Japan (Tsukuba University Department of Biology) in 1997 and got into PhD program in Biotechnology in the following year. In June 2002, I joined Chemotaxis Signaling Section, Laboratory of Immunogenetics in National Institutes of Allergy and Infectious Diseases (NIAID/NIH) as a visiting fellow. My research focused on developing and applying state of art imaging technology to monitor signaling network of G protein coupled receptor mediated chemotaxis in model organism Dictyostelium. Four years later, I was recruited as an assistant professor at Department of Oncology and the director of Dynamic Imaging, Microscopy Core Shared Resources (MCSR), Georgetown University School of Medicine. In 2010, I came back NIAID/NIH as a staff scientist until present.
Dr. Mehdi Mirsaeidi received his MD at the University of Qazvin and his MPH at the University of Tehran. He completed an Infectious Diseases residency at the University of Shaheed Beheshti, and HIV clinical training in Montpellier, France. After a four-year faculty appointment in the Department of Medicine at Shaheed Beheshti, he began an Infectious Diseases fellowship at the University of Louisville in Kentucky. He followed this fellowship with an Internal Medicine residency at the George Washington University/ Providence Hospital in DC. The finished a 3-year Pulmonary and Critical Care fellowship at University of Illinois at Chicago.He was awarded a
Dr. Mehdi Mirsaeidi received his MD at the University of Qazvin and his MPH at the University of Tehran. He completed an Infectious Diseases residency at the University of Shaheed Beheshti, and HIV clinical training in Montpellier, France. After a four-year faculty appointment in the Department of Medicine at Shaheed Beheshti, he began an Infectious Diseases fellowship at the University of Louisville in Kentucky. He followed this fellowship with an Internal Medicine residency at the George Washington University/ Providence Hospital in DC. The finished a 3-year Pulmonary and Critical Care fellowship at University of Illinois at Chicago.He was awarded a T32 NIH award on 2013. His research continues to focus on pulmonary infections (particularly mycobacterial diseases) and sarcodosis. He has published extensively on pulmonary infections such as TB, NTM, and pneumonia.
Dr. Ayse Baccioglu recieved her MD and Pulmonary Residency from University of Ankara School of Medicine in Turkey. She completed her Allergy and Clinical Immunology residency with Prof. Dr. Kalpaklioglu in Kirikkale University and is a current assistant professor at the same Institution (2010). She worked with Prof. Holgate and Prof. Djukanovic about cell culture techniques in the respiratory laboratory of Respiratory, Allergy and Infection Unit of Southampton University School of Medicine, UK. She has membership in the Turkish National Society of Allergy and Clinical Immunology, American Academy of Allergy, Asthma & Immunology, European Academy of Allergy and Clinical Immunology,
Dr. Ayse Baccioglu recieved her MD and Pulmonary Residency from University of Ankara School of Medicine in Turkey. She completed her Allergy and Clinical Immunology residency with Prof. Dr. Kalpaklioglu in Kirikkale University and is a current assistant professor at the same Institution (2010). She worked with Prof. Holgate and Prof. Djukanovic about cell culture techniques in the respiratory laboratory of Respiratory, Allergy and Infection Unit of Southampton University School of Medicine, UK. She has membership in the Turkish National Society of Allergy and Clinical Immunology, American Academy of Allergy, Asthma & Immunology, European Academy of Allergy and Clinical Immunology, European Respiratory Society, and World Allergy Organization. Along with these she has authored/co-authored over 20 peer-reviewed publications in international journals and conferences. Her research interests include non-allergic rhinitis, drug allergy, and asthma.
Dr. Luzheng Xue is a Senior Research Fellow, Principal Investigator and Group Leader in the University of Oxford. He received his PhD degree from the University of Siena, Italy and the Chinese Academy of Sciences in 1991 and did his postdoctoral research at the MRC Laboratory for Molecular Cell Biology UCL and the University of Dundee from 1992 to 1996. Then he worked at the University of Cambridge as a Senior Research Associate for 5 years before he joining the Oxagen Limited, UK as a Principal Scientist, Leader of Cell Biology/Immunology in 2001 working on preclinical drug development to treat
Dr. Luzheng Xue is a Senior Research Fellow, Principal Investigator and Group Leader in the University of Oxford. He received his PhD degree from the University of Siena, Italy and the Chinese Academy of Sciences in 1991 and did his postdoctoral research at the MRC Laboratory for Molecular Cell Biology UCL and the University of Dundee from 1992 to 1996. Then he worked at the University of Cambridge as a Senior Research Associate for 5 years before he joining the Oxagen Limited, UK as a Principal Scientist, Leader of Cell Biology/Immunology in 2001 working on preclinical drug development to treat allergic diseases.Some drugs have successfully completed Phase II clinical trial in asthmatic and rhinitis patients and is now preparing for Phase III trial. He moved his group into the University of Oxford in 2010.His group is investigating the roles and mechanisms of type II immunity in allergic inflammation. Research Interests include the roles and mechanisms of type II immunity, particularly CRTH2 positive cells, in allergic inflammation and drug development.
Enrico Heffler, M.D., specialised in Allergy and Clinical Immunology,Ph.D. in Experimental Medicine and Therapy at University of Torino (Italy). 2009-2014: Allergist in different hospitals in Piedmont region. Since the beginning of 2015 he is a Researcher in Respiratory Medicine at University of Catania, Italy. His research was mainly focused on the study of inflammatory mechanisms of asthma, rhinitis and rhinosinusitis, human anaphylaxis, and food allergy, publishing more than 55 scientific articles in international peer-reviewed scientific journals and 3 book chapters. Heffler is actively involved in the activity of the European Academy of Allergy and Clinical Immunology (EAACI) (previously as
Enrico Heffler, M.D., specialised in Allergy and Clinical Immunology,Ph.D. in Experimental Medicine and Therapy at University of Torino (Italy). 2009-2014: Allergist in different hospitals in Piedmont region. Since the beginning of 2015 he is a Researcher in Respiratory Medicine at University of Catania, Italy. His research was mainly focused on the study of inflammatory mechanisms of asthma, rhinitis and rhinosinusitis, human anaphylaxis, and food allergy, publishing more than 55 scientific articles in international peer-reviewed scientific journals and 3 book chapters. Heffler is actively involved in the activity of the European Academy of Allergy and Clinical Immunology (EAACI) (previously as Junior Members & Affiliates Chairperson and Executive Committee member; currently as member of the Asthma Section Board) and of the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) (previously as Junior Members National Coordinator, then member of the Executive Committee, and currently Secretary General).
Dr Efimia Papadopoulou-Alataki is Assistant Professor in Pediatrics/ Pediatric immunology, Aristotle University of Thessaloniki, Greece. She works as paediatrician- clinical immunologist at Fourth Department of Pediatrics in Papageorgiou Hospital of Thessaloniki. She has acquired clinical and research experience at Medizinische Hochschule, Hannover, Germany and at Great Ormont Street Hospital for children, London, United Kingdom. As academic scientist, she is actively involved in teaching and research in the field of pediatric immunology. She served as a reviewer for International Archives of Allergy and Immunology, Pediatric Drugs, BMC Gastroenterology, First Consult. She is member in international organizations including ESID
Dr Efimia Papadopoulou-Alataki is Assistant Professor in Pediatrics/ Pediatric immunology, Aristotle University of Thessaloniki, Greece. She works as paediatrician- clinical immunologist at Fourth Department of Pediatrics in Papageorgiou Hospital of Thessaloniki. She has acquired clinical and research experience at Medizinische Hochschule, Hannover, Germany and at Great Ormont Street Hospital for children, London, United Kingdom. As academic scientist, she is actively involved in teaching and research in the field of pediatric immunology. She served as a reviewer for International Archives of Allergy and Immunology, Pediatric Drugs, BMC Gastroenterology, First Consult. She is member in international organizations including ESID (European Society of Immunodeficiency) and EAACI. She is editorial board member in Journal of Case Reports and Studies. Research interest include allergic diseases, clinical immunology, Hereditary Angioedema, Primary Immunodeficiencies, autoimmune -autoinflammatory diseases, vaccinations.
George Bertsias received his M.D. from the University of Crete in 2002 and after completing his Internship in 2004 he enrolled in the graduate program 'Molecular Basis of Human Diseases' (UoCSM) from which he obtained a M.Sc. degree in 2006 and a Ph.D. in Immunology in 2009. He went on to complete his training in Internal Medicine and Clinical Immunology-Rheumatology and he was board certified in 2011. In the same year, Dr. Bertsias moved to Bethesda (MD, USA) to work in the laboratory of Dr. Daniel Kastner at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National
George Bertsias received his M.D. from the University of Crete in 2002 and after completing his Internship in 2004 he enrolled in the graduate program 'Molecular Basis of Human Diseases' (UoCSM) from which he obtained a M.Sc. degree in 2006 and a Ph.D. in Immunology in 2009. He went on to complete his training in Internal Medicine and Clinical Immunology-Rheumatology and he was board certified in 2011. In the same year, Dr. Bertsias moved to Bethesda (MD, USA) to work in the laboratory of Dr. Daniel Kastner at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Institute of Human Genome Research Institute, National Institutes of Health. Since 2008, Dr. Bertsias has been member of the European League Against Rheumatism (EULAR) study group and Task Force on SLE where he has supervised and conducted the systematic literature review for preparation of the EULAR recommendations for the diagnosis and management of SLE in general and for specific manifestations (neuropsychiatric, nephritis). In 2012 he was elected Lecturer in Rheumatology-Clinical Immunology and became Principal Investigator at the Laboratory of Autoimmunity and Inflammation, UoCSM. He is running the Connective Tissue Diseases Outpatient Clinic at the University Hospital of Heraklion. Dr. Bertsias main scientific interests are in systemic autoimmune diseases (especially SLE), including aspects of the disease epidemiology and outcomes, immune regulation through lymphocyte costimulatory receptors, and transcriptomics.
Dr. KUO, Ho-Chang Kuo, graduated from National Yang-Ming University, Taiwan with a M.D. degree in 1999 and PhD degree from Graduate Institute of Clinical Medical Science at Chang Gung University, Taiwan in 2011. Dr. Kuo worked as an attending pediatrician, physician scientist and associate Professor at Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Taiwan. Now, I am also the Direct of Kawasaki Disease Center of Kaohsiung Chang Gung Memorial Hospital, Taiwan. My research interesting was mainly focus on Kawasaki disease. I had published more than 105 peer-reviewed SCI journal papers including 2 Nature Genetics (2011 and 2012) and
Dr. KUO, Ho-Chang Kuo, graduated from National Yang-Ming University, Taiwan with a M.D. degree in 1999 and PhD degree from Graduate Institute of Clinical Medical Science at Chang Gung University, Taiwan in 2011. Dr. Kuo worked as an attending pediatrician, physician scientist and associate Professor at Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Taiwan. Now, I am also the Direct of Kawasaki Disease Center of Kaohsiung Chang Gung Memorial Hospital, Taiwan. My research interesting was mainly focus on Kawasaki disease. I had published more than 105 peer-reviewed SCI journal papers including 2 Nature Genetics (2011 and 2012) and 55 Kawasaki disease papers. I am ranked as 1st Top Expert of Kawasaki disease in Asia by Expertscape.com.
Bibi Lange, graduate as medical doctor from University of Southern Denmark (1996-2003). She received her PhD degree from the department of Otorhinolaryngology Odense University Hospital and University of Southern Denmark. She is currently a resident in Otorhinolaryngology, Head and neck Surgery. She is supervisor for medical students in their pregraduate research and serves as ad-hoc reviewer for several journals. Her work and research encompass the clinical and epidemiological field and focuses the diseases of rhinology such as rhinosinusitis, nasal polyps, allergic rhinitis, and sinonasal tumours including relation to the lower airways. She is a member of the Danish Rhinologic Society
Bibi Lange, graduate as medical doctor from University of Southern Denmark (1996-2003). She received her PhD degree from the department of Otorhinolaryngology Odense University Hospital and University of Southern Denmark. She is currently a resident in Otorhinolaryngology, Head and neck Surgery. She is supervisor for medical students in their pregraduate research and serves as ad-hoc reviewer for several journals. Her work and research encompass the clinical and epidemiological field and focuses the diseases of rhinology such as rhinosinusitis, nasal polyps, allergic rhinitis, and sinonasal tumours including relation to the lower airways. She is a member of the Danish Rhinologic Society and the European Rhinologic Society.
Sadegh Samadi studied in Tehran University of Medical Sciences, where he obtained a BSc degree in Occupational Health. After graduation he joined the Occupational Health Division at the Health Center of Arak University of Medical Sciences. He received his MSc degree in Occupational Health from Tarbiat Modares University, Tehran, Iran. In 1999 he joined the Department of Health in Arak University of Medical Sciences where he worked as a lecturer. He then in 2006 was awarded a grant, by Health of Ministry and Medical Education of Iran, to pursue his education as a PhD at the Division of Environmental Epidemiology
Sadegh Samadi studied in Tehran University of Medical Sciences, where he obtained a BSc degree in Occupational Health. After graduation he joined the Occupational Health Division at the Health Center of Arak University of Medical Sciences. He received his MSc degree in Occupational Health from Tarbiat Modares University, Tehran, Iran. In 1999 he joined the Department of Health in Arak University of Medical Sciences where he worked as a lecturer. He then in 2006 was awarded a grant, by Health of Ministry and Medical Education of Iran, to pursue his education as a PhD at the Division of Environmental Epidemiology (EEPI) of the Institute for Risk Assessment Sciences (IRAS), Utrecht University, the Netherlands. From July 2011 to September 2012 he worked on his Postdoctoral fellow at Utrecht University. Since September 2012, he is working as an assistant professor at the department of occupational health in Arak University of Medical Sciences. His main research interests are in the field of Environmental and Occupational Health Sciences particularly exposure assessments and epidemiological studies with focus on dose-response studies relevant to, for example, allergy/sensitization, asthma, and respiratory and skin diseases.
I received my PhD from Warsaw Institute of Mother and Child in 2002. My interests focus mainly on the adverse food reaction e.g. food allergy and intolerance and gastrointestinal tract diseases . I am the author/coauthor of more than 150 publications in peer-revieved scientific national and international journals. I presented my research at numerous conferences. I am a member of Polish Society of Gastroenterology, Hepatology and Child Nutrition ( section of Allergology and Endoskopy).
I received my PhD from Warsaw Institute of Mother and Child in 2002. My interests focus mainly on the adverse food reaction e.g. food allergy and intolerance and gastrointestinal tract diseases . I am the author/coauthor of more than 150 publications in peer-revieved scientific national and international journals. I presented my research at numerous conferences. I am a member of Polish Society of Gastroenterology, Hepatology and Child Nutrition ( section of Allergology and Endoskopy).
Arzu Didem Yalcin is an Assistant Professor of Allergy/Immunology at Academia Sinica, Taiwan, Near East University and Antalya Training and Research Hospital.She completed her Medical Doctorate from Gazi University School of Medicine. She received Allergy/Immunology Fellowship Certificate from University of Akdeniz, Department of Allergy/Immunology. She published more than 90 peer review publications in different scientific journals. She acted as sub-investigator for many clinical research studies. She interest on Antibody engineering technology and strategies in developing new antibody therapeutics. SIROCCO,(BENRALIZUMAB,ANTI-IL5) ,Sweeden. Aninternational non-interventional registry on the quality of life of patients with pollen-induced Allergic rhinitis Treated with ORALAIR France.Xolair, anti-CemX
Arzu Didem Yalcin is an Assistant Professor of Allergy/Immunology at Academia Sinica, Taiwan, Near East University and Antalya Training and Research Hospital.She completed her Medical Doctorate from Gazi University School of Medicine. She received Allergy/Immunology Fellowship Certificate from University of Akdeniz, Department of Allergy/Immunology. She published more than 90 peer review publications in different scientific journals. She acted as sub-investigator for many clinical research studies. She interest on Antibody engineering technology and strategies in developing new antibody therapeutics. SIROCCO,(BENRALIZUMAB,ANTI-IL5) ,Sweeden. Aninternational non-interventional registry on the quality of life of patients with pollen-induced Allergic rhinitis Treated with ORALAIR France.Xolair, anti-CemX antibody targeting mIgE-expressing B cells and anti-migis antibodies that spesifically target mIgA-expressing Bcells or mIgD-expressing B.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97